← Back to Analyst Consensus 
ACTU Buy
ACTUATE THERAPEUTICS, INC.
Current Price —
Implied Upside —
Analysts 9
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 13, 2026 (18 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 18, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Jul 30, 2026 | Rodman & Renshaw | initiate | — → Buy | — | 40% |
| May 18, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Apr 22, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Apr 13, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Nov 19, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Sep 23, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Aug 26, 2025 | B. Riley Securities | initiate | — → Buy | $20 | 55% |
| Aug 18, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Mar 17, 2025 | HC Wainwright & Co. | initiate | — → Buy | $20 | 44% |
Price Target Trend
Apr 1, 2026 Oct 26, 2026
EPS Estimates
0q —
+1q —
0y —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days